2.16.840.1.113883.5.1070/static-2012-07-24
| Codesystem Name | Codesystem Id | Version / Eingangsdatum | Status | |
|---|---|---|---|---|
| substanceAdminSubstitution | 2.16.840.1.113883.5.1070 | 2012-07-24 | definitiv | |
| Level/Typ | Code | Anzeigename | Beschreibung | |
| 0-A | _ActSubstanceAdminSubstitutionCode | (en-US) ActSubstanceAdminSubstitutionCode | Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects. | |
| 1-S | E | (en-US) equivalent | Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product. | |
| 2-S | EC | (en-US) equivalent composition | Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril | |
| 3-L | BC | (en-US) brand composition | Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven | |
| 3-L | G | (en-US) generic composition | Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp) | |
| 2-S | TE | (en-US) therapeutic alternative | Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet | |
| 3-L | TB | (en-US) therapeutic brand | Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics> Examples: Zantac for Tagamet | |
| 3-L | TG | (en-US) therapeutic generic | Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands> Examples: Ranitidine for cimetidine | |
| 1-L | F | (en-US) formulary | Description: This substitution was performed or is permitted based on formulary guidelines. | |
| 1-L | N | (en-US) none | No substitution occurred or is permitted. |
|
